Status:
RECRUITING
Association Between Stroke and Adrenal Incidentalomas
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Stroke
Adrenal Incidentaloma
Eligibility:
All Genders
18-100 years
Brief Summary
Adrenal incidentalomas (AIs) are commonly encountered in transsection imaging which purpose not for suspected adrenal disease. However, part of AIs in patients is associated with Stroke. Stroke is a d...
Detailed Description
Background: Adrenal incidentalomas (AIs) are commonly encountered in transsection imaging which purpose not for suspected adrenal disease. However, part of AIs in patients is associated with Stroke ....
Eligibility Criteria
Inclusion
- stroke disease , such as Cerebral infarction、Intracerebral hemorrhage and Subarachnoid hemorrhage.
Exclusion
- presence of metastatic cancer;
- AIs smaller than 1 cm;
- nonadenoma lesions, such as myelolipomas,hemorrhages, and cysts;
- oral glucocorticoid treatment with more than single doses in the past 3 months;
- use of inhaled steroids or medication affecting dexamethasone metabolism;
- systemic estrogen treatment.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2029
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT05237817
Start Date
April 1 2021
End Date
February 28 2029
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hao Yan
Beijing, China, 100053